Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

Heavy trading · Indonesia stocks

PT Jayamas Medica Industri Tbk (OMED) volume jumps to 4.3 times its average

The price rose 4.6% on the day, to IDR 226.00.

Published 9 October 2026 · Written from Tradzy's price and volume data

Close
IDR 226.00
On the day
+4.6%
Volume
4.3× average
vs 52-week high
−27.1%

PT Jayamas Medica Industri Tbk closing prices

IDR 200.00IDR 225.00IDR 250.00Jun '26Jun '26Jul '26Aug '26Sep '26Oct '26IDR 226.00

The last 90 closes up to 9 October 2026. The live chart is on the OMED page.

What happened

PT Jayamas Medica Industri Tbk (OMED) closed at IDR 226.00 on 9 October 2026, up 4.6% from IDR 216.00 the session before.

Over 5 sessions the price is up 5.6%, and over 20 sessions it is up 5.6%.

The close is 27.1% below the highest close of the past year (IDR 310.00 on 23 Apr 2026) and 24.9% above the lowest (IDR 181.00 on 2 Jul 2026).

Trading was heavy: volume was 4.3 times its average of the sessions before.

Across the 69 IDX stocks we track, 35 closed higher and 30 closed lower that day, with a median change of +0.65%. OMED's change was +4.6%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeIDR 216.00
CloseIDR 226.00
Change on the day+4.63%
Change over 5 sessions+5.61%
Change over 20 sessions+5.61%
Volume34.88 Million
Average volume, up to 20 sessions before8.10 Million
Volume against that average4.3 times
Highest close in the past yearIDR 310.00 (23 Apr 2026)
Lowest close in the past yearIDR 181.00 (2 Jul 2026)

The full chart and history are on PT Jayamas Medica Industri Tbk (OMED). More from this market: IDX news today.

More IDX moves on 9 October 2026

Want a plan for OMED? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.